PVLA · Palvella Therapeutics, Inc. · Documents
Market Cap
$2.18B
Shares
14.41M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-08-12 | 2026-09-30 | |
| 8-K | 2026-08-04 | — | |
| 10-Q | 2026-08-04 | 2026-06-30 | |
| 8-K | 2026-07-14 | — | |
| 8-K | 2026-06-30 | 2026-06-29 | |
| 8-K | 2026-06-16 | 2026-06-10 | |
| Investor Event Transcript | 2026-06-09 | 2026-06-30 | |
| 8-K | 2026-05-20 | — | |
| 8-K | 2026-05-15 | — | |
| 8-K | 2026-05-13 | 2026-05-11 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-30 | 2026-06-10 | |
| 8-K | 2026-04-13 | — | |
| 8-K | 2026-04-07 | — | |
| 8-K | 2026-03-31 | — | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-02-26 | 2026-02-25 | |
| 8-K | 2026-02-24 | — | |
| 8-K | 2026-02-24 | — | |
| 8-K | 2026-02-24 | — | |
| 8-K | 2026-01-29 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-15 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-11-05 | — | |
| 8-K | 2025-09-24 | — | |
| 8-K | 2025-09-03 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-14 | — | |
| 8-K | 2025-06-11 | 2025-06-10 | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-15 | — | |
| DEF 14A | 2025-04-30 | 2025-06-10 | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-03-31 | — | |
| 8-K | 2025-03-04 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-16 | 2024-12-13 | |
| 8-K | 2024-12-12 | 2024-12-11 | |
| 8-K | 2024-12-03 | 2024-12-02 | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| DEF 14A | 2024-11-06 | 2024-12-02 | |
| 8-K | 2024-10-03 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-08 | 2024-08-07 | |
| 8-K | 2024-07-24 | 2024-07-23 | |
| 8-K | 2024-07-03 | 2024-06-28 | |
| 10-Q | 2024-05-15 | 2024-03-31 |
Showing 1–50 of 141 filings
Key facts
CIK
1583648
CUSIP
697947109
13F (30d)
130 filings
130 filers
Visit website
Investor relations